Dxcover

The Future of Cancer Diagnostics

[Dxcover @Dxcover]

#Dxcover #LiquidBiopsy #EarlierDetection #Innovation

[Dxcover @Dxcover]

#Dxcover #BrainCancer #EarlierDetection #PatientCare

[Dxcover @Dxcover]

Abigail is joining the All Party Parliamentary Group (#appg) for a session on #LessSurvivableCancers.
The @LessSurvivable focuses on patients affected by cancers of the brain, liver, lungs, pancreas, oesophagus, and stomach and advocates for action to improve survival rates.

[Dxcover @Dxcover]

#Dxcover #Spectroscopy #Cancer #EarlyDetection

[Dxcover @Dxcover]

#UterineCancer is the most common #Gynecologic cancer in the US and UK, and the n. of cases is expected to increase by 50% by 2045*
June is #UterineCancerAwarenessMonth, a timely reminder of raising awareness to support earlier diagnosis and improve outcomes.
*IARC & #IGCS
#UCAM

[Dxcover @Dxcover]

Did you see Prof. Paul Brennan's blog earlier this week?
Read his perspective on the importance of innovation in earlier cancer detection: https://t.co/i4bwL10gfW
#Dxcover #MedTech #Innovation #CancerDetection

[Dxcover @Dxcover]

https://t.co/bNdE1ldpBd

[Dxcover @Dxcover]

#ASCO26 highlighted new therapies that demonstrate impressive improvements in median overall survival for #pancreatic and #ovarian #cancer patients. What might be possible if more patients could benefit from breakthroughs at earlier stages thanks to earlier detection? #MedTech

[Dxcover @Dxcover]

On #WorldBrainTumorDay, we stand with everyone affected by a #BrainCancer diagnosis, remember those we have lost, and acknowledge the dedication of researchers. Dxcover is proud to work towards #EarlyDetection with the UKCA and CE-IVDR marked Brain Cancer Liquid Biopsy test.

[Dxcover @Dxcover]

Dxcover’s CEO Matthew Baker will present today as part of the Grand Rounds U.S. 2026.
#Dxcover #GrandRounds #Seattle2026 #MedTech #Cancer #EarlyDiagnosis #LiquidBiopsy

[Dxcover @Dxcover]

Dxcover is heading to Seattle to present at Grand Rounds U.S. 2026, showcasing how our AI-driven spectral diagnostic platform is redefining early cancer detection.
#Dxcover #GrandRounds #Seattle2026 #MedTech #Cancer #EarlyDiagnosis #LiquidBiopsy

[Dxcover @Dxcover]

Looking forward to seeing you at the #ASCO26 CNS Tumours Session, Board 417, between 1:30 and 4:30 PM!
The #Dxcover #BrainCancer test continues to demonstrate consistently high performance in independent clinical datasets.
#EarlyDiagnosis #LiquidBiopsy

[Dxcover @Dxcover]

Today at #ASCO26, #Dxcover is showcasing their latest work in #PancreaticCancer, highlighting consistently strong performance detecting early-stage disease.
Hope to see you at the GI Cancer session, Board 212, between 9 AM and 12 PM!
#EarlyDiagnosis #LiquidBiopsy #ASCO26 #PDAC

[Dxcover @Dxcover]

Looking forward to seeing you in Chicago at the #ASCO26 Annual Meeting starting today!
#EarlyDiagnosis #LiquidBiopsy #Dxcover #ASCO26

[Dxcover @Dxcover]

Our CTO, Dr Holly Butler, will be sharing insights from Dxcover’s journey developing a spectroscopy-based liquid biopsy test during her invited keynote talk at #SPEC2026 – the clinical spectroscopy community’s biennial conference.
See you in Nashville!

[Dxcover @Dxcover]

Dxcover will be presenting at the #ASCO26 Annual Meeting later this month, sharing more compelling data about Dxcover’s UKCA & CE-IVDR-marked #BrainCancer Detection test.
Get in touch to schedule an in-person meeting at ASCO: https://t.co/wQG9HvqNe9
#EMBRACE #EarlyDiagnosis

[Dxcover @Dxcover]

Early diagnosis and timely intervention in #CRC are key to improving patient outcomes. We demonstrated 97% sensitivity, with consistently high performance across both early and advanced disease in a prospective study of ~1,000 US patients.
#EarlyDiagnosis #LiquidBiopsy #MedTech

[Dxcover @Dxcover]

𝐇𝐨𝐰 𝐅𝐚𝐫 𝐖𝐞’𝐯𝐞 𝐂𝐨𝐦𝐞, 𝐇𝐨𝐰 𝐅𝐚𝐬𝐭 𝐖𝐞’𝐫𝐞 𝐌𝐨𝐯𝐢𝐧𝐠!
A piece by Matthew Baker PhD, Co-Founder & CEO of Dxcover
Read it here: https://t.co/yzspUEoD7P

[Dxcover @Dxcover]

Our Dxcover #BrainCancer PE Study went from 1st patient through full data analysis in just 18 months: https://t.co/ONbc8MpCM6
Last week at #AACR2026 we celebrated key progress made in cancer research, and most of all...
#EarlyDiagnosis #LiquidBiopsy #PatientCare

[Dxcover @Dxcover]

#AACR2026 Poster #5115 shared additional findings on #CRC earlier detection.
Small sample input, low cost per test, and fast TAT make Dxcover an ideal complement for multiple modalities.
If you missed us at AACR, get in touch: https://t.co/wQG9HvqNe9
#EarlyDiagnosis #LiquidBiopsy